Technology
Health
Medical

Biolase

$1.99
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

$0.00 (0.00%) Today
+$0.01 (0.51%) After Hours

Why Robinhood?

You can buy or sell Biolase and other stocks, options, ETFs, and crypto commission-free!

About

Biolase, Inc. Common Stock, also called Biolase, is a medical device company, which engages in the development, manufacture, market and sale of laser systems in dentistry and medicine. Read More It operates through Waterlase (all-tissue) systems, and Diode (soft-tissue) systems products. The Waterlase systems uses a patented combination of water and laser energy to perform procedures using drills, scalpels, and other traditional dental instruments for cutting soft and hard tissue. The Diode systems performs soft tissue, pain therapy, and cosmetic procedures, including teeth whitening. The company was founded in 1987 and is headquartered in Irvine, CA.

Employees
190
Headquarters
Irvine, California
Founded
1987
Market Cap
42.16M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
55.39K
High Today
$2.01
Low Today
$2.01
Open Price
$2.01
Volume
750.00
52 Week High
$2.87
52 Week Low
$0.91

Collections

Technology
Health
Medical
Energy
Therapy
US
North America

News

Yahoo FinanceMay 9

BIOLASE Reports First Quarter 2019 Results

- First Quarter U.S. Laser Revenue Increased 18% Year-Over-Year - First Quarter Operating Loss Decreased 16% Year-Over-Year IRVINE, Calif., May 9, 2019 /PRNewswire/ -- BIOLASE, Inc. (BIOL), the global leader in dental lasers, today reported net revenue of $10.3 million for the first quarter ended March 31, 2019, an increase of 3% compared to the first quarter of 2018. Scroll to continue with content Ad BIOLASE Logo (PRNewsfoto/BIOLASE, Inc.) First Quarter Highlights U.S. laser revenue increased 18% ye...

8
PR NewswireMay 6

BIOLASE, Inc to Report First Quarter 2019 Results on May 9, 2019

IRVINE, Calif., May 6, 2019 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release first quarter 2019 financial and operating results on Thursday, May 9, 2019 after the close of the U.S. financial markets and will host a conference call and webcast that day at 4:30 p.m. ET / 1:30 p.m. PT to discuss the results and corporate developments. For both "listen-only" participants and those participants who wish to take part in the question-and-answer...

19
Yahoo FinanceApr 27

Edited Transcript of BIOL earnings conference call or presentation 5-Mar-19 9:30pm GMT

Q4 2018 BIOLASE Inc Earnings Call IRVINE Apr 27, 2019 (Thomson StreetEvents) -- Edited Transcript of BIOLASE Inc earnings conference call or presentation Tuesday, March 5, 2019 at 9:30:00pm GMT TEXT version of Transcript ================================================================================ Corporate Participants ================================================================================ * John R. Beaver BIOLASE, Inc. - Executive VP & CFO * Todd A. Norbe BIOLASE, Inc. - President, CE...

18

Earnings

-$0.20
-$0.15
-$0.09
-$0.04
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 7, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.